Treventis scientists and advisors attend and present at ALS/MND 2020
Treventis scientists Drs. Christopher Barden and Ross Mancini and SAB member Dr. […]
Archives: News
Treventis attends Virtual AAIC 2020
Treventis was well represented at the Alzheimer Association International Conference, running from […]
Treventis founders awarded funding for COVID-19 clinical trial
LifeArc, a major UK-based charity, has announced funding for Treventis founders Dr. […]
Treventis attends Virtual BIO Conference
Not to be deterred by COVID-19, Treventis attended the BIO Digital International […]
Treventis attends 8th Neurodegenerative Drug Development Summit
Treventis CSO Mark Reed was in attendance at the 8th Neurodegenerative Drug […]
Treventis Attends Tau2020 Conference
Treventis VP Research Marcia Taylor has attended Tau2020 in Washington, DC, which […]
Treventis founders publish new computational methodology for brain drug design
Treventis founders Dr. Donald Weaver, Mark Reed, and Christopher Barden have supervised […]
Treventis attends BioPort Atlantic Conference
Treventis CEO Christopher Barden attended BioPort, Atlantic Canada’s largest health and life […]
Treventis gives invites presentation at Texas Life Science Forum
Treventis CSO Mark Reed attended the Texas Life Science Forum on November […]
Treventis attends the 2nd Neuromuscular Drug Development Summit (NMD)
CEO Christopher Barden attended the NMD Summit in Boston, Massachusetts, where he […]